Articles

• Proactive Versus Reactive Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease and Rheumatology: Evidence, Thresholds and Pharmacist-Led Implementation

  Dr. Shivaraj D R, Bhoganandish VG, Punya shree GR

  • PDF

• Analytical Quality by Design Approach to a Green Chromatographic Method for Simultaneous Estimation of a Fixed-Dose Combination: Method Greenness Assessment Using AGREE and Blue Applicability Grade Index

  Pratik V Dhakne

  • PDF

• Lyophilised and Thermostable mRNA-Lipid Nanoparticle Vaccines: Excipient Selection, Process Design and Cold-Chain-Independent Distribution for Low- and Middle-Income Countries

  Anish Verma, Sarbjot Singh, Anita Devi

  • PDF

• Machine Learning Guided Formulation Design: From Descriptor-Based Prediction of Solubility and Stability to Autonomous Self-Driving Formulation Laboratories

  Rajat Bhattacharjee

  • PDF

• Molecular Glue Degraders Versus Heterobifunctional PROTACs: A Comparative Analysis of Mechanism, Physicochemical Space, Selectivity and Clinical Progress

  Priyanka Kushwaha

  • PDF

• Nose-to-brain drug delivery for neurodegenerative disease: critical appraisal of evidence, translational barriers and standards for preclinical reporting

  Dr Shivaraj D R, Mrs. Varsha N S, Dr Abhishek B V

  • PDF

• Machine Learning in Pharmaceutical Formulation Development: From Molecular Descriptors and Property Prediction to Closed-Loop Autonomous Experimentation

  Mahima Beohar, Dr. Megha Verma, Anupam Jaiswal

  • PDF

• In silico repurposing of approved drugs against NDM-1: an appraisal of the consensus docking and molecular dynamics evidence, with chemoinformatic re-analysis of the proposed candidates

  Jyoti Pandit, Anshika Nautiyal

  • PDF

• Direct Nose-to-Brain Transport in Central Nervous System Disorders: Appraising the Quality of Preclinical Evidence and Establishing Standards for Its Reporting

  Jyoti Pandit, Sunaina

  • PDF

• Anti-Amyloid Monoclonal Antibodies in Alzheimer Disease: Weighing Modest Clinical Benefit Against ARIA Risk, Cost and Health System Readiness in Low- and Middle-Income Countries

  Dr. Shivaraj D R, Ms. Indira A R, Ms. Harshitha N L

  • PDF

• Generative Artificial Intelligence in De Novo Drug Design: Validation Frameworks, Benchmarking Failures and What the First AI-Discovered Clinical Candidates Have Actually Taught Us

  Dr. Shivaraj D R, Ms. Rachana M A, Ms. T Pushpanjali

  • PDF

• Antibody-Drug Conjugates in Solid Tumours: Linker and Payload Engineering, Bystander Effect, Resistance Mechanisms and Management of Interstitial Lung Disease

  Dr. Shivaraj D R, Ms. Kusuma D S, Ms. Yashaswini Raj

  • PDF

• Natural-Product Inspired Drug Discovery Revisited: Genome mining, Synthetic Biology and Artificial Intelligence for Reviving an Underexploited Chemical Space

  Dr. Megha Verma, Anupam Jaiswal, Mahima Beohar

  • PDF

• Thiolated Mucoadhesive Polymers (Thiomers)

  Reetu Kumari

  • PDF

• Managing Rifampicin-Based Drug Interactions in Tuberculosis Co-Treatment: Mechanistic Basis, Class-by-Class Management Strategies and Decision Support for High-Burden Settings

  Dr. Shivaraj D R, Ms. Harshitha N L, Ms. Rachana M A, Ms. T Pushpanjali

  • PDF

• Dissolving Microneedle Patches: A Next- Generation Approach for Painless and Targeted Drug Delivery

  Priyanshi Singh, Akash Rawat, Dr. Vaibhav Rajoriya

  • PDF